Abdol Hamid Shahinfar, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 200 High Service Ave, Radiology Department, North Providence, RI 02904 Phone: 413-456-4215 Fax: 401-456-3019 |
Stephen R Ellin, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 200 High Service Ave, Radiology Department, North Providence, RI 02904 Phone: 401-456-4215 Fax: 401-456-3019 |
James F Aiken, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 200 High Service Ave, Radiology Department, North Providence, RI 02904 Phone: 401-456-4215 Fax: 401-456-3019 |
Steven Weisblatt, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 200 High Service Avenue, North Providence, RI 02904 Phone: 401-572-3120 Fax: 401-572-3351 |
Warren W Bovie, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 200 High Service Ave, Radiology Department, North Providence, RI 02904 Phone: 401-456-4215 Fax: 401-456-3019 |
Nicholas D Iannuccilli, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1515 Smith St, Ste 6, North Providence, RI 02911 Phone: 401-353-1600 |
News Archive
Thinking twice about what you flush away may help you save money, and the environment. Today, Ryerson University released a new report on the first ever test of single-use wipes against rigorous criteria for flushability.
The Society of Interventional Radiology Foundation's Discovery campaign will benefit from a $500,000 pledge by new "Futurist" level supporter, medical device manufacturer AngioDynamics.
Scientists have revealed that an anti-obesity drug changes the way the brain responds to appetising, high-calorie foods in obese individuals. This insight may aid the development of new anti-obesity drugs which reduce the activity in the regions of the brain stimulated by the sight of tasty foods.
An international effort led by researchers at the Perelman School of Medicine at the University of Pennsylvania has resulted in positive phase 3 clinical trial results for a new medicine to treat patients suffering from a rare and deadly cholesterol disorder.
The fourth annual American Association for Cancer Research Team Science Award will be given to Dana-Farber/Harvard Cancer Center Thoracic Oncology Research Team at the AACR 101st Annual Meeting 2010. This research team is comprised of interdisciplinary investigators from the Dana-Farber Cancer Institute, Brigham and Women's Hospital, Massachusetts General Hospital, Beth Israel Deaconess Medical Center and Harvard Medical School.
› Verified 4 days ago